GENEVA, March 22 (Reuters) - The COVAX facility has brought
30 million doses of COVID-19 vaccine to 50 countries and is on
track to deliver 300 million doses by the end of the 2nd quarter
but some suppliers are having "teething problems", a senior WHO
official said on Monday.
"The problem is we simply cannot get enough vaccine,
manufacturers now are not able to keep up with our orders,"
Bruce Aylward, a senior WHO adviser and coordinator of the ACT
(Access to COVID-19 Tools) Accelerator, told a news conference.
(Reporting by John Miller, Emma Farge, Silke Koltrowitz;
writing by Stephanie Nebehay)
CORRECT: Angle shares up on assay development deal with AstraZeneca
(Correcting company name in headline)
Read more